Kumari Priyanka
Research Subjects
Kumari Priyanka has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Eranna Lokesha
Division of Animal Nutrition, ICAR-Indian Veterinary Research Institute, Izatnagar, 243122, India
1 shared publication - Ganesh Narayanrao Aderao
ICAR-Indian Institute of Agricultural Biotechnology, Ranchi, Jharkhand, India
1 shared publication - Gyanendra Singh
Division of Physiology and Climatology, ICAR-Indian Veterinary Research Institute, Izatnagar, 243122, India
1 shared publication - Kiran Dip Gill
Department of Biochemistry, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India
1 shared publication - Narayan Dutta
ICAR-Indian Veterinary Research Institute
1 shared publication - Pramod Chaudhary
Division of Animal Nutrition, ICAR-Indian Veterinary Research Institute, Izatnagar, 243122, India
1 shared publication
Latest Publications
- 25 April 2025
- Published by Elsevier in Journal of Trace Elements in Medicine and Biology
- Vol. 89, 127662
Heat stress demands high dietary zinc to combat oxidative stress, and improve cytokine and immune response in rats
- 25 April 2025
- Published by Elsevier in Journal of Trace Elements in Medicine and Biology
- Vol. 89, 127662
Heat stress demands high dietary zinc to combat oxidative stress, and improve cytokine and immune response in rats
- Open Access
- 3 December 2019
- Published by MDPI AG in Biomolecules
- Vol. 9 (12) , 817
Paraoxonase 3: Structure and Its Role in Pathophysiology of Coronary Artery Disease
Spanning three decades in research, Paraoxonases (PON1) carried potential of dealing with neurotoxicity of organophosphates entering the circulation and preventing cholinergic crisis. In the past few years, the Paraoxonase multigene family (PON1, PON2, PON3) has been shown to play an important role in pathogenesis of cardiovascular disorders including coronary artery disease (CAD). The PON genes are clustered in tandem on the long arm of human chromosome 7 (q21, 22). All of them have been shown to act as antioxidants. Of them, PON3 is the least studied member as its exact physiological substrate is still not clear. This has further led to limitation in our understanding of its role in pathogenesis of CAD and development of the potential therapeutic agents which might modulate its activity, expression in circulation and tissues. In the present review, we discuss the structure and activity of human PON3 enzyme and its Single nucleotide variants that could potentially lead to new clinical strategies in prevention and treatment of CAD.
- 3 December 2019
- Published by MDPI AG in Biomolecules
- Vol. 9 (12) , 817
Open AccessParaoxonase 3: Structure and Its Role in Pathophysiology of Coronary Artery Disease
Spanning three decades in research, Paraoxonases (PON1) carried potential of dealing with neurotoxicity of organophosphates entering the circulation and preventing cholinergic crisis. In the past few years, the Paraoxonase multigene family (PON1, PON2, PON3) has been shown to play an important role in pathogenesis of cardiovascular disorders including coronary artery disease (CAD). The PON genes are clustered in tandem on the long arm of human chromosome 7 (q21, 22). All of them have been shown to act as antioxidants. Of them, PON3 is the least studied member as its exact physiological substrate is still not clear. This has further led to limitation in our understanding of its role in pathogenesis of CAD and development of the potential therapeutic agents which might modulate its activity, expression in circulation and tissues. In the present review, we discuss the structure and activity of human PON3 enzyme and its Single nucleotide variants that could potentially lead to new clinical strategies in prevention and treatment of CAD.